Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-198337
Filing Date
2024-08-12
Accepted
2024-08-12 06:48:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 d129092d424b5.htm 424B5 446757
2 GRAPHIC g129092g00m04.jpg GRAPHIC 41186
3 GRAPHIC g129092g25s01.jpg GRAPHIC 53210
4 GRAPHIC g129092g25s02.jpg GRAPHIC 102261
5 GRAPHIC g129092g25s03.jpg GRAPHIC 62491
6 GRAPHIC g129092g25s04.jpg GRAPHIC 106098
7 GRAPHIC g129092g59z83.jpg GRAPHIC 58824
  Complete submission text file 0001193125-24-198337.txt   1013509
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277886 | Film No.: 241194681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)